43. Urticaria, angioedema

A case of Telangiectasia Macularis Eruptiva Perstans

Malvina Baikstiene, Matilda Bylaite-bucinskiene

Omalizumab for treatment of different types of chronic urticaria - our experience

A. Bergant Suhodolcan, M. Benko

Increased serum soluable VE-cadherin levels in patients with chronic spontaneous urticaria

Tao Chen, Zai-pei Guo, Wen-ju Wang, Li-xin Fu, Qiao-mei Sun, Pei-mei Zhou

Decreased interleukin-35 serum levels in patients with chronic spontaneous urticarial

Tao Chen, Qiao-mei Sun, Li-xin Fu

Chronic spontaneous urticaria: autoimmune subtypes and immunologic features

Yudi Chen

Omalizumab is effective in symptomatic dermographism: a prospective clinical analysis

Yudi Chen, Peng Geng, Zuotao Zhao

Epidemic Yellow Fever Immunization: Is that a problem to Omalizumab treatment?

Paulo Ricardo Criado, Roberta Fachini Criado, Luis Felipe Ensina, Laura Ramos De Almeida, Karine Corsione Turke, Carolina Bensi

Subcutaneous Autologous Serum Therapy vs. Conventional Intramuscular Autologous Serum Therapy in Chronic Urticaria: A Randomised, Controlled Trial Comparing the Effectiveness and Safety

A Datta, S Chandra, A Sil, A Saha, Nk Das

The prevalance of FCER1A gene polymorphism in patients with chronic spontaneous urticaria and its effect on omalizumab treatment responses

Ece Nur Degirmentepe, Pelin Kuteyla Can, Emek Kocaturk

Italian real life study on Omalizumab in chronic spontaneous urticaria: clinical efficacy, safety, predictors of treatment outcome and time to response.

A. Detoraki, L. Cegolon, E. Di Leo, F. Lodi Rizzini, W.g. Canonica, E. Nettis, Ocurel Group

Diffuse cutaneous mastocytosis: study of 12 cases

Sandipan Dhar

Omalizumab in the treatment of mast cell disorders: a systematic literature review

Jendoubi Fatma, Paul Carle, Bulai Livideanu Cristina

Omalizumab for the treatment of chronic inducible urticarias: a real-life study

M Fialek, F Dezoteux, D Staumont-sallé

Real Life Management of Chronic Urticaria: multicenter and cross sectional study on patients and dermatologists in Iran

A Firooz, Aa Akhlaghi, F Abdollahimajd, H Azimi, M Banihashemi, Ar Erfani, S Farajzadeh, Mr Ghassemi, M Gheisari, Kh Hamedpour, F Handjani, Sa Hashemi, H Herizchi, F Iraji, A Khatami, V Lajevardi, P Mansouri, H Masjedi, P Mehrian, S Mohammadi, A Mohebbi, N Namazi, M Nasiri Kashani, A Radmehr, Z Saffarian, S Saneei, S Seirafi, S Taheri, Mj Yazdanpanah, N Zaboli Nejad

HIGH LEVELS OF IGE AGAINST TISSUE FACTOR AND THYROGLOBULIN ARE REDUCED BY OMALIZUMAB IN CHRONIC SPONTANEOUS URTICARIA

Giovanni Genovese, Riccardo Asero, Silvia Ferrucci, Maurizio Lorini, Vincenzo Carbonelli, Emilio Berti, Angelo Valerio Marzano, Massimo Cugno

More Patients Treated with Ligelizumab are Angioedema-free compared with Omalizumab: Results of a Phase II Clinical Trial

Ana Giménez-arnau, Gordon Sussman, Marcus Maurer, Eva Hua, Kenneth Kobayashi, Reinhold Janocha, Thomas Severin, Maria-magdalena Balp

UPDOSING OF DESLORATADINE IN CHRONIC SPONTANEOUS URTICARIA

Gauri Godse

ADVANCED URTICARIA MANAGEMENT

Kiran Godse

SKINWRITOMETER FOR DIAGNOSIS OF DERMOGRAPHISM

Kiran Godse

Erythema multiforme or urticaria multiforme?

A Gunaric, M Prlic, J Zeljko Penavic, D Simic

Diagnostic Utility of Food-specific IgG4 in Chronic Urticaria with Suspected Food Intolerance

B Han, Ys Kim, Mw Choi, Ty Han, J Hk Lee

Evaluation of Factors Affecting Drug Survival and Treatment Responses of The Patients With Chronic Urticaria on Omalizumab Treatment

Eda Hasal, Emel Bulbul Baskan, Serkan Yazici, Kenan Aydogan, Hayriye Saricaoglu

Bullous Mastocytosis in an adult: A rare presentation

Mk Hunjan, A Adel, C Grattan

Impact of self medication practices to Urticaria, Impact on Daily Life in developing country

M Joshi

Assessment Of Knowledge Attitude and Practice of patients with chronic urticaria

Dhan Khadka, Sudha Agrawal, Arpana Rijal

Epidemiology and comorbidities of patients with chronic urticaria in Korea: A nationwide population-based study

Br Kim, S Yang, Jw Choi, Cw Choi, Sw Youn

Behavior of peripheral basophils in an urticaria patient treated with omalizumab.

Izumi Kishimoto, Naotomo Kambe, Thi My Nhung Ly, Thi Hong Chuyen Nguyen, Hiroyuki Okamoto

Omalizumab versus Cyclosporin-A for the treatment of Chronic Spontaneous Urticaria: is there specific patient characteristics or biomarkers to indicate response to treatment?

E Kocaturk, E Bulbul Baskan, O Su Kucuk, M Ozdemir, S Ornek, P Ulkumen, E Hasal

Efficacy of Omalizumab in patients with Chronic Inducible Urticaria; clinical experience from a UCARE center

E Kocaturk, Pk Can, Sa Ornek

Autoimmune thyroiditis and stress impairs treatment responses to omalizumab in chronic urticaria and patients with angioedema and higher body-mass-index may require longer treatment

E Kocaturk, K Kiziltac, Pk Can

Is it urticarial vasculitis or urticaria that resembles urticarial vasculitis?

E Kocatürk, S Özekinci, Sa Örnek

BECK depression scores change significantly after omalizumab treatment in patients with chronic spontaneous urticaria and presence of depression might impair response to omalizumab

Emek Kocaturk, Piril Etikan, Ece Nur Degirmentepe, Pelin Kuteyla Can

Evaluation of a low-dose methotrexate added to H1-antihistamines regimen for severe chronic spontaneous urticaria: a phase III, randomized, placebo-controlled trial

Sophie Leducq, Mahtab Samimi, Claire Bernier, Angèle Soria, Emmanuelle Amsler, Delphine Staumont-salle, Germaine Gabison, Olivier Chosidow, Nathalie Beneton, Corina Bara, Anne Grange-prunier, Ewa Wierzbicka-hainaut, Emilie Brenaut, Catherine Droitcourt, Nadia Raison-peyron, Bruno Giraudeau, Hélène Bourgoin, Hélène Cornillier, Laurent Machet, Agnès Caille, Annabel Maruani

The determinants of urticaria in Lebanon: A case-control study

I Maatouk, R Ballout, P Salameh

Long-term follow-up of the treatment with omalizumab in patients with chronic spontaneous urticaria: evidence from real-life.

Gm Maini, M Esposito, Mc Fargnoli

Effect of Omalizumab Treatment on Disease Activity in Chronic Spontaneous/Idiopathic Urticaria: Results from XTEND-CIU, a Longitudinal Perspective

M Maurer, T Murphy, M Holden, A Iqbal, B Yoo, T Casale

Short courses of cyclosporine control CSU in patients with low IgE

F Morgado, L Santiago, M Gonçalo

Epidemiology of Urticaria Chronic in Kinshasa

Christian Muteba Baseke, Boye Ramata

A retrospective study on natural history of chronic urticaria in Korea

Cw Park, Yw Choi, Mj Jung, By Chung, Ho Kim

Chronic spontaneous urticaria in treatment with Omalizumab: case series

Viviana Piras, Myriam Zucca, Franco Rongioletti

Aquagenic Urticaria: A case report and review of the literature

A Robles Tenorio, G Sierra Silva, Vm Tarango Martínez, Le Rocha Mendez

The effectiveness and safety of higher doses of omalizumab in patients with chronic spontaneous urticaria: Real-life data from a retrospective cohort study

A Salman, E Comert

Cholinergic and aquagenic pruritus responding to gabapentin

Jennifer Sharif, Liezel Griffin, Alexander Marsland

An Investigator-Blind Randomised Controlled Trial Comparing the Effectiveness, Safety and Tolerability of Levocetrizine and Bepotastine in Chronic Urticaria

Amrita Sil, Nasiruddin Mondal, Sufiur Rahaman, Aparesh Patra, Sudipta Roy, Pinaki Sarkar, Nilay Das

Characteristics and determinants of patient burden and needs in the treatment of chronic spontaneous urticarial

Rachel Sommer, Anna Katharina Langenbruch, Marcus Maurer, Petra Staubach, Matthias Augustin

Curative effect of high-dose Levocetirizine in treating recalcitrant chronic spontaneous urticaria and the serum IP3 concentration detection

Renshan Sun, Xianqiong Huang

Successful treatment of severe cholinergic urticaria with omalizumab

Hideaki Tanizaki, Aoi Yamasaki, Shinichi Moriwaki

Efficacy and safety of Omalizumab in patients affected by several comorbidities: data from real-life clinical practice

Laura Vollono, Laura Diluvio, Eleonora Di Matteo, Caterina Lanna, Maria Esposito, Luca Bianchi

Serum miR-125a-5p elevates in chronic spontaneous/idiopathic urticaria and correlates with treatment response

Ting Xiao, Li-ming Zhang, Rui-qun Qi, Yang Yang, Xing-hua Gao, Hong-duo Chen

Plasmapheresis as a treatment for severe refractory Aquagenic Pruritus and Urticaria

W Ye, A Eissa, S Grabczynska

Effect of YKL-40 on permeability of human dermal microvascular endothelial cells

Peimei Zhou, Lixin Fu

Serum Vitamin D and Vitamin D Binding Protein Levels Decrease in Patients with Urticaria and Its Possible Role in Pathogenesis

Yiqi Zhu, Duoqin Wang, Yixin Shao, Jinhua Xu, Hui Tang